159 related articles for article (PubMed ID: 32388230)
1. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia.
Paneesha S; Pratt G; Parry H; Moss P
Leuk Res; 2020 Jun; 93():106366. PubMed ID: 32388230
[No Abstract] [Full Text] [Related]
2. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
Scarfò L; Chatzikonstantinou T; Rigolin GM; Quaresmini G; Motta M; Vitale C; Garcia-Marco JA; Hernández-Rivas JÁ; Mirás F; Baile M; Marquet J; Niemann CU; Reda G; Munir T; Gimeno E; Marchetti M; Quaglia FM; Varettoni M; Delgado J; Iyengar S; Janssens A; Marasca R; Ferrari A; Cuéllar-García C; Itchaki G; Špaček M; De Paoli L; Laurenti L; Levin MD; Lista E; Mauro FR; Šimkovič M; Van Der Spek E; Vandenberghe E; Trentin L; Wasik-Szczepanek E; Ruchlemer R; Bron D; De Paolis MR; Del Poeta G; Farina L; Foglietta M; Gentile M; Herishanu Y; Herold T; Jaksic O; Kater AP; Kersting S; Malerba L; Orsucci L; Popov VM; Sportoletti P; Yassin M; Pocali B; Barna G; Chiarenza A; Dos Santos G; Nikitin E; Andres M; Dimou M; Doubek M; Enrico A; Hakobyan Y; Kalashnikova O; Ortiz Pareja M; Papaioannou M; Rossi D; Shah N; Shrestha A; Stanca O; Stavroyianni N; Strugov V; Tam C; Zdrenghea M; Coscia M; Stamatopoulos K; Rossi G; Rambaldi A; Montserrat E; Foà R; Cuneo A; Ghia P
Leukemia; 2020 Sep; 34(9):2354-2363. PubMed ID: 32647324
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report.
Cuneo A; Scarfò L; Reda G; Varettoni M; Quaglia FM; Marchetti M; De Paoli L; Re F; Pietrasanta D; Rigolin GM; Orsucci L; Ibatici A; Gattei V; Mauro FR; Trentin L; Laurenti L; Marasca R; Foà R
Blood; 2020 Aug; 136(6):763-766. PubMed ID: 32559271
[No Abstract] [Full Text] [Related]
4. Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19.
Thibaud S; Tremblay D; Bhalla S; Zimmerman B; Sigel K; Gabrilove J
Br J Haematol; 2020 Jul; 190(2):e73-e76. PubMed ID: 32433778
[No Abstract] [Full Text] [Related]
5. Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia.
Roeker LE; Knorr DA; Pessin MS; Ramanathan LV; Thompson MC; Leslie LA; Zelenetz AD; Mato AR
Leukemia; 2020 Nov; 34(11):3047-3049. PubMed ID: 32855439
[No Abstract] [Full Text] [Related]
6. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
Goetz L; Yang J; Greene W; Zhu Y
J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
[No Abstract] [Full Text] [Related]
7. CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report.
Baumann T; Delgado J; Montserrat E
Leukemia; 2020 Jul; 34(7):1954-1956. PubMed ID: 32433507
[No Abstract] [Full Text] [Related]
8. A Case of COVID-19-Induced Lymphocytosis in a Patient With Treatment-Naive CLL: Should It Be treated?
Safarpour D; Srinivasan K; Farooqui M; Roth C; Ghouse M
Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):69-72. PubMed ID: 33039356
[No Abstract] [Full Text] [Related]
9. Chronic Lymphocytic Leukemia Concomitant with COVID 19: A Case Report.
Ali E; Badawi M; Abdelmahmuod E; Kohla S; Yassin MA
Am J Case Rep; 2020 Oct; 21():e926062. PubMed ID: 33098641
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and fortuitous discovery of chronic lymphocytic leukemia: biological findings and therapeutic challenges.
Charra B; Ellouadghiri A; Magramane A; Kebbou T; Damaan K; Maghfour A; Seddiki K; Ezzouine H
Pan Afr Med J; 2020; 36():286. PubMed ID: 33117480
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 and severity of COVID-19 patients in Hefei, China.
Zhao Z; Xie J; Yin M; Yang Y; Ding C; Gao Y; Ma X
Med Mal Infect; 2020 Oct; 50(7):629-631. PubMed ID: 32593746
[TBL] [Abstract][Full Text] [Related]
12. Safety first: evidence for delay of radical prostatectomy without use of androgen deprivation therapy during COVID-19.
Sean Ong XR; Condon B; Bagguley D; Lawrentschuk N; Azad A; Murphy D
Future Oncol; 2020 Jul; 16(20):1409-1411. PubMed ID: 32407145
[No Abstract] [Full Text] [Related]
13. When CLL meets COVID-19.
Montserrat E
Blood; 2020 Sep; 136(10):1115-1116. PubMed ID: 32882019
[No Abstract] [Full Text] [Related]
14. Follow-up of asymptomatic patients with SARS-CoV-2 infection.
Zhou X; Li Y; Li T; Zhang W
Clin Microbiol Infect; 2020 Jul; 26(7):957-959. PubMed ID: 32234453
[No Abstract] [Full Text] [Related]
15. Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.
Haghjooy Javanmard S; Vaseghi G; Manteghinejad A; Nasirian M
J Glob Antimicrob Resist; 2020 Sep; 22():862-863. PubMed ID: 32810639
[TBL] [Abstract][Full Text] [Related]
16. Postmortem Examination of Patients With COVID-19.
Schaller T; Hirschbühl K; Burkhardt K; Braun G; Trepel M; Märkl B; Claus R
JAMA; 2020 Jun; 323(24):2518-2520. PubMed ID: 32437497
[TBL] [Abstract][Full Text] [Related]
17. Neuropathological Features of Covid-19.
Solomon IH; Normandin E; Bhattacharyya S; Mukerji SS; Keller K; Ali AS; Adams G; Hornick JL; Padera RF; Sabeti P
N Engl J Med; 2020 Sep; 383(10):989-992. PubMed ID: 32530583
[No Abstract] [Full Text] [Related]
18. Adrenal Vascular Changes in COVID-19 Autopsies.
Iuga AC; Marboe CC; M Yilmaz M; Lefkowitch JH; Gauran C; Lagana SM
Arch Pathol Lab Med; 2020 Oct; 144(10):1159-1160. PubMed ID: 32579380
[No Abstract] [Full Text] [Related]
19. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia.
De Biasi S; Lo Tartaro D; Meschiari M; Gibellini L; Bellinazzi C; Borella R; Fidanza L; Mattioli M; Paolini A; Gozzi L; Jaacoub D; Faltoni M; Volpi S; Milić J; Sita M; Sarti M; Pucillo C; Girardis M; Guaraldi G; Mussini C; Cossarizza A
Eur J Immunol; 2020 Sep; 50(9):1283-1294. PubMed ID: 32910469
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 Pneumonia in Patients With HIV: A Case Series.
Okoh AK; Bishburg E; Grinberg S; Nagarakanti S
J Acquir Immune Defic Syndr; 2020 Sep; 85(1):e4-e5. PubMed ID: 32483000
[No Abstract] [Full Text] [Related]
[Next] [New Search]
